Executives Worried as Elon Musk’s Ongoing Drug Use Raises Concerns

Date:

Executives and board members at various companies led by Elon Musk are reportedly growing concerned about his ongoing drug use, according to a report in the Wall Street Journal. Sources familiar with Musk and his businesses claim that he continues to consume drugs, particularly ketamine, despite his prescription for the substance as an antidepressant. The report further alleges that Musk has used LSD, cocaine, ecstasy, and psychedelic mushrooms at private parties. However, Musk’s lawyer has stated that he is subjected to regular and random drug testing at SpaceX and has never failed a test.

One incident that drew attention to Musk’s drug use was his public consumption of marijuana during a podcast with Joe Rogan in September 2018. The Pentagon subsequently reviewed the federal security clearance tied to his role as CEO of SpaceX. Musk responded to the accusation on social media, stating that he agreed to three years of random drug testing at NASA’s request after the podcast and that no trace amounts of drugs or alcohol were found.

The report also mentions Linda Johnson Rice, a Tesla director since 2017, who allegedly did not seek reelection due to frustration with Musk’s behavior and drug use.

Elon Musk is known for overseeing six companies: Tesla, SpaceX, X (formerly known as Twitter), The Boring Co., Neuralink, and xAI – an artificial intelligence startup.

While concerns about Musk’s drug use and behavior have been raised, it is essential to present a balanced view and consider different perspectives. The impact of his drug use on his professional responsibilities and the effectiveness of his leadership should be thoroughly assessed. Companies and their stakeholders may need to address these concerns and evaluate the potential consequences for their respective organizations.

See also  Elon Musk Announces Integration of X Social Media Platform with Tesla Fleet

As this news highlights ongoing concerns surrounding one of the most influential figures in the tech industry, it is crucial to monitor how these revelations may impact Musk’s business ventures and relationships with stakeholders moving forward.

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.